Sera Prognostics (SERA) Current Deferred Revenue (2021 - 2026)
Sera Prognostics' (SERA) quarterly Current Deferred Revenue came in at $20.3 million in Q1 2026, little changed YoY from $20.2 million in Q1 2025, and little changed on a QoQ basis from $20.3 million in Q4 2025.
Sera Prognostics (SERA) Current Deferred Revenue (2021 - 2026) Analysis & Trends
Sera Prognostics (SERA) has 6 years of Current Deferred Revenue data on file, last reported at $20.3 million in Q1 2026.
- Quarterly Current Deferred Revenue changed 0.44% year-over-year to $20.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.3 million (changed 0.44% YoY) and the FY2025 annual result came in at $20.3 million, changed 0.45% from the prior year.
- Current Deferred Revenue held at $20.3 million in Q1 2026, from $20.3 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $20.3 million in Q3 2025 to a low of $3.1 million in Q2 2022.
- A 5-year average of $16.1 million and a median of $20.2 million in 2024 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2022 — Current Deferred Revenue soared 6433.81% — and 2024, when it decreased 0.06%.
- Tracing SERA's Current Deferred Revenue over 5 years: stood at $9.1 million in 2022, then surged by 122.8% to $20.2 million in 2023, then fell by 0.06% to $20.2 million in 2024, then increased by 0.45% to $20.3 million in 2025, then fell by 0.02% to $20.3 million in 2026.
- The last three Current Deferred Revenue figures came in at $20.3 million (Q1 2026), $20.3 million (Q4 2025), and $20.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Sera Prognostics | 103.48 Mn | 103.48 Mn | -20,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.30 Mn |
| Mar 31, 2026 | 20.31 Mn |
| Dec 31, 2025 | 20.32 Mn |
| Sep 30, 2025 | 20.32 Mn |
| Jun 30, 2025 | 20.22 Mn |
| Mar 31, 2025 | 20.22 Mn |
| Dec 31, 2024 | 20.22 Mn |
| Sep 30, 2024 | 20.23 Mn |
| Jun 30, 2024 | 20.23 Mn |
| Mar 31, 2024 | 20.23 Mn |
| Dec 31, 2023 | 20.24 Mn |
| Sep 30, 2023 | 9.04 Mn |
| Jun 30, 2023 | 9.05 Mn |
| Mar 31, 2023 | 9.07 Mn |
| Dec 31, 2022 | 9.08 Mn |
| Jun 30, 2022 | 3.10 Mn |
| Dec 31, 2021 | 139,000.00 |
| Sep 30, 2021 | 139,000.00 |
| Jun 30, 2021 | 138,000.00 |